## HON: Honeywell International Inc. - XLI: Industrials

### Executive Summary

No thesis match: MRS_20 0.5% below STRENGTH zone (4.0-10.0%); PEG 1.83 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge. Caution: declining volume (53% of avg).

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($189.47)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_20 falling below -5% or breaking key support

### News

- **Articles:** 10
- **Sentiment:** Bullish (Bullish: 3, Bearish: 1)

**1. Honeywell (HON) stock slips as Pentagon posts $58.8 million Army contract modification**
- Source: ts2.tech | 20251231T042218 | Somewhat-Bearish | Relevance: 100%
- Honeywell (HON) shares fell 0.37% after the Pentagon announced a $58.8 million contract modification for the company's AGT 1500 engine-platform support work. Investors are keeping an eye on industrial names, particularly in defense and aerospace, as they also watch Fed policy signals and upcoming jobs data. The contract modification brings Honeywell's total contract value to $2.689 billion, running through March 31, 2028.

**2. Honeywell International Inc. (NASDAQ:HON) Receives Consensus Recommendation of "Hold" from Analysts**
- Source: MarketBeat | 20251230T220800 | Neutral | Relevance: 100%
- Honeywell International Inc. (NASDAQ:HON) has received a consensus "Hold" recommendation from nineteen analysts, with an average 12-month target price of $235.58. Recent analyst adjustments include price target cuts from Argus and Jefferies, and new "neutral" coverage from BNP Paribas Exane, while HSBC and TD Cowen maintained "buy" ratings despite lowering their targets. Fundamentally, Honeywell reported $2.25 EPS on $8.95 billion revenue and has a market capitalization of approximately $125.1 billion.

**3. Jim Cramer is Enthusiastic About Honeywell (HON) Split**
- Source: Finviz | 20251230T040812 | Somewhat-Bullish | Relevance: 100%
- Jim Cramer expresses enthusiasm for Honeywell's (HON) split, particularly highlighting the value in its aerospace and chemical segments, despite a recent $470 million charge related to FlexJet. The company is dividing into three firms, with Solstice Advanced Materials already trading and Honeywell Aerospaceâ€™s separation expected next year, attracting varied analyst ratings. Cramer believes the core business remains very valuable, especially the chemical company which he views as the cheapest in the sector.

**4. Honeywell secures $58.8 million contract modification from U.S. Army**
- Source: Investing.com | 20251229T220751 | Bullish | Relevance: 100%
- Honeywell International Inc. has been awarded a $58.79 million contract modification by the U.S. Department of War for services related to the automotive gas turbine 1500 engine platform. This modification increases the total contract value to $2.69 billion. The work is expected to be completed by March 31, 2028, with funding and specific locations determined by individual orders.

**5. Honeywell Reveals Possible Charges, Payments To Settle Flexjet Lawsuit**
- Source: Aviation International News | 20251229T180516 | Bearish | Relevance: 100%
- Honeywell announced potential charges and payments totaling $470 million to resolve a lawsuit filed by Flexjet in 2023. The lawsuit alleges a breach of an engine maintenance agreement concerning Honeywell HTF engines, which power aircraft such as Flexjet's Embraer Praetor 600s. The company is currently negotiating a settlement.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 0, Lowers: 2)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-24 | Barclays | $250 | $269 | -7% |
| 2025-12-15 | Evercore ISI Gr | $255 | $0 | 0% |
| 2025-12-04 | Barclays | $269 | $270 | -0% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-24 | Barclays | main | Overweight |
| 2025-12-15 | Evercore ISI Gr | init | Outperform |
| 2025-12-04 | Barclays | main | Overweight |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **MIXED** |
| Buys | 3 ($0.00M) |
| Sells | 4 ($0.00M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 35.1% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 5 / 5 |

**Top Holders:**
- Vanguard Group Inc: 8.9% (-0.3%)
- Blackrock Inc.: 7.1% (+6.1%)
- State Street Corpora: 4.4% (-0.8%)
- JPMORGAN CHASE & CO: 3.0% (+112.5%)
- Morgan Stanley: 2.7% (+0.1%)

### Key Risks

1. Market regime shift could impact momentum names disproportionately.
2. Sector rotation risk if leadership changes from current market theme.
3. Earnings execution risk on next quarterly report.

### Catalysts

- Broader market risk-on sentiment could lift quality names.
- Year-end positioning and window dressing may support price.

### Fundamentals

PEG ratio 1.83 elevated, pricing in significant growth expectations. Forward P/E 18.4x stretched relative to 0% growth. Quality metrics strong (ROE 35%, margin 15%). Balance sheet: $2.9B free cash flow. Analyst sentiment negative (2 target cuts vs 0 raises). Institutional flow bullish (5 buying vs 5 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $131.5B |
| Beta | 0.95 |
| 52W Range | $169.05 - $227.82 |
| Short Interest | 1.5% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 1.83 |
| Forward P/E | 18.4 |
| Current P/E | 18.5 |
| YoY Growth | 0.0% |
| EPS Direction | STABLE |

### Technicals

MRS_20 stable at 0.5% (minimal 5-day change). Below STRENGTH zone by 3.5pp (needs >4.0% for momentum thesis). MRS_5 at 0.2% confirms short-term momentum alignment. Below SMA200 (0.96x), long-term trend not supportive. RSI neutral at 49. Volume at 53% of 20MA suggests lack of conviction. OFD pattern: -MUL (Resistance).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | 0.47% (CS: 58) | Neutral |
| RSI_14 | 48.8 | Neutral |
| MACD Histogram | 0.04 | Bullish |
| vs SMA20 | 0.999x | Below |
| vs SMA50 | 0.996x | Below |
| vs SMA200 | 0.965x | Below |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $195.09
- **Stop Loss:** $189.47 (2.9% risk)
- **Target:** $200.71 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 213
- **Position Value:** $41,554.17
- **Portfolio %:** 41.55%
- **Risk Dollars:** $1,200.00
- **Risk Per Trade:** 1.20%
- **Modifiers:** L1 120% | L2 100% | Combined 1.20x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.20x |
| L2 Sector | NEUTRAL (Zone E) | 1.00x |

*NORMAL regime with mixed signals requiring caution. VIX at 14.95 suggests calm markets, but record repo borrowing and narrowing breadth (51.4%) indicate stress beneath the surface. Positive yield curve (+62bps) and stable economic data support risk assets, but year-end dynamics mask true liquidity conditions.*

### Earnings

**Next:** 2026-02-05 (Est: $2.57)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $2.57 | $2.82 | +9.9% |
| 2025Q2 | $2.66 | $2.75 | +3.4% |
| 2025Q1 | $2.21 | $2.51 | +13.6% |
| 2024Q4 | $2.35 | $2.47 | +5.3% |

---
*RULE-based L3 | 2026-01-06 16:38 | MRS_20*